Market Place
Sourcing Support
Jubilant`s Generics Solifenacin Receives Tentative Approval in US
02 Oct 2024 //
FDA
Jubilant Pharmova to close Mfg Solid dosage facility of Jubilant Cadista USA
19 Apr 2024 //
INDINPHARMAPOST
Jubilant gets VAI classification from USFDA for Roorkee unit
17 Apr 2024 //
ECONOMICTIMES
FDA slams Jubilant Generics, Canada`s Contract Pharmaceuticals with Form 483s
09 Apr 2024 //
FIERCE PHARMA
FDA Issues form 483 to Jubilant Generics
05 Apr 2024 //
FDA
Jubilant Generics` Roorkee site completes USFDA audit
03 Feb 2024 //
BUSINESS STANDARD
USFDA determines inspection classification of Jubilant Pharmova`s Roorkee
31 Oct 2022 //
INDIANPHARMAPOST
FDA Issues Form 483 to Jubilant Generics Ltd.
27 Oct 2022 //
FDA
Indian site for Jubilant Generics lands Form 483 for QC issues
26 Oct 2022 //
ENDPTS
Jubilant Generics (Roorkee) is on Health Canada Inspection List
13 Oct 2021 //
HEALTH CANADA
FDA issues form 483 to Jubilant Generics
20 Aug 2021 //
FDA
FDA blasts Indian manufacturer`s site for unclean conditions in Form 483 letter
19 Aug 2021 //
ENDPTS
FDA Issues Form 483 to Jubilant Generics Limited
17 Aug 2021 //
FDA
Granules India, Jubilant Cadista recall products in US market
11 Aug 2021 //
BUSINESS-STANDARD
Jubilant Generics is on FDA Import Alert List
14 Jul 2021 //
FDA
Jubilant Generics Limited is on FDA Import Alert List
14 Jul 2021 //
FDA
Enforcement Report - Week of April 21, 2021
22 Apr 2021 //
FDA
Jubilant Life Sciences raises ?90 crore through commercial papers
25 Nov 2020 //
LIVEMINT
Aavis Pharma, Jubilant launch hydroxychloroquine sulfate tablets in US market
06 Nov 2020 //
PHARMABIZ
Saptagir Labs signs manufacturing deal with Jubilant Generics for remdesivir
15 Sep 2020 //
EXPRESS PHARMA
Analysts positive on Jubilant Life despite 52% dip in Q1 profit; here`s why
06 Sep 2020 //
BUSINESSSTANDARD
Jubilant Life Sciences sustaining operational, financial performance
23 Aug 2020 //
ECONOMICTIMES
Jubilant Life Sciences launches generic version of remdesivir for COVID-19
03 Aug 2020 //
MONEYCONTROL
Jubilant Generics receives DCGI approval to market `JUBI-R` (remdesivir)
20 Jul 2020 //
SCIENCEDAILY
India poised to ramp up remdesivir production as Mylan & Jubilant Life Sciences
02 Jul 2020 //
PHARMABIZ
Zydus Cadila signs licensing pact with Gilead for covid-19 drug remdesivir
13 Jun 2020 //
LIVEMINT
India approves emergency use of remdesivir to treat COVID-19 patients
03 Jun 2020 //
REUTERS
Gilead ties up with generic drugmakers for COVID-19 drug supply
13 May 2020 //
REUTERS
Jubilant Life inks non-exclusive licensing pact with Gilead for Remdesivir
12 May 2020 //
BUSINESS-STANDARD
Jubilant Life Sciences says no traces of Covid-19 in raw material imported
16 Apr 2020 //
ECONOMICTIMES
Jubilant rules out role of imported raw material from China for COVID-19
09 Apr 2020 //
PHARMABIZ
Jubilant rules out role of imported raw material from China COVID-19 infection
08 Apr 2020 //
PHARMABIZ
Jubilant arm receives US FDA approval for generic Anafranil
25 Oct 2019 //
PHARMABIZ
Q BioMed Announces Commercial Partnership With Jubilant Radiopharma
07 Oct 2019 //
BIOSPACE
Jubilant Life extends fall on weak Q4 results; stock hits 33-month low
29 May 2019 //
BUSINESS-STANDARD
Buy Jubilant Life Sciences; target of Rs 750: Dolat Capital
23 May 2019 //
MONEYCONTROL
Rising OAIs bring spotlight back on regulatory compliance at Indian pharma
21 May 2019 //
MONEYCONTROL
Jubilant Life Sciences Q4 net loss at Rs 100 cr
17 May 2019 //
MONEYCONTROL
Top trading ideas by Prabhudas Lilladher: Buy Jubilant Life, Cipla
10 Apr 2019 //
BUSINESSWIRE
Jubilant Generics Ltd. Receives FDA Form 483
03 Apr 2019 //
FDA
Jubilant Life Sciences settles IFC loan with USD 135 mn payout
29 Mar 2019 //
ECONOMICTIMES
Jubilant Life Sciences hits four-month low; falls 21% in five days
26 Mar 2019 //
BUSINESS-STANDARD
USFDA classifies Jubilant Life`s Nanjangud facility as `Official Action Indicated`
26 Mar 2019 //
MOMEYCONTROL
FDA warns Jubilant tablet plant in India for repeat mistakes
14 Mar 2019 //
FIERCE PHARMA
Jubilant Generics Limited Receives FDA Warning Letter
13 Mar 2019 //
FDA
Jubilant Biosys strengthens collaboration with Sanofi in CNS Diseases
13 Feb 2019 //
PR NEWSWIRE
USFDA recommends regulatory action after Jubilant Life`s Roorkee plant inspection
10 Dec 2018 //
ECONOMIC TIMES
Enforcement Report - Week of August 29, 2018
29 Aug 2018 //
FDA
Jubilant Generics Niacin Receives Approval In US
16 May 2018 //
FDA
Ruby-Fill® (Rubidium-82): Bracco Diagnostics v. Jubilant Draximage
27 Mar 2018 //
PATENT LITIGATION
Aptiom® (Eslicarbazepine Acetate) : Bial - Portela v. Jubilant Life Sciences
01 Mar 2018 //
PATENT LITIGATION
Aptiom® (Eslicarbazepine Acetate):Bial - Portela & CA S.A. v. Jubilant
01 Mar 2018 //
PATENT LITIGATION
Jubilant Pharma gets USFDA nod for Symmetrel`s generic version
09 Feb 2018 //
ECONOMIC TIMES
Jubilant Generics Clonidine hydrochloride Receives Approval In US
31 Jan 2018 //
FDA
Jubilant Life gains on ANDA approval for generic drug
30 Jan 2018 //
BUSINESS-STANDARD
Jubilant Pharma completes Triad`s US radiopharmacy acquisition
05 Sep 2017 //
ECONOMIC TIMES
Jubilant`s Generic Indomethacin Receives Approval In US
29 Aug 2017 //
FDA
Jubilant`s Generic Tizanidine Hydrochloride Receives Approval In US
09 Aug 2017 //
FDA
Jubilant Life Sciences gets USFDA nod for anti-depressive drug
06 Jul 2017 //
ECONOMIC TIMES
